title: Clinical potential of a new HIV protease inhibitor.
authors.affiliation: Agouron Pharmaceuticals, La Jolla, CA.
authors.forename: S
authors.initials: S
authors.lastname: Chapman
authors.forename: J
authors.initials: J
authors.lastname: Peterkin
authors.forename: B
authors.initials: B
authors.lastname: Quart
authors.forename: M
authors.initials: M
authors.lastname: Youle
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D015658:HIV Infections; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000235:genetics / Q000302:isolation & purification; D008297:Male; D019888:Nelfinavir; D012367:RNA, Viral / Q000097:blood
chemical_list: D000998:Antiviral Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral; D019888:Nelfinavir